Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy

Amira Barkal, Kipp Weiskopf, Kevin S. Kao, +15

Nature Immunology

Cancer ImmunosurveillanceMhc ClassImmunologyImmunologic MechanismAntigen Processing +6

A CD47-associated super-enhancer links pro-inflammatory signalling to CD47 upregulation in breast cancer

Paola Betancur, Brian J. Abraham, Ying Ying Yiu, +15

Nature Communications

An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes

Yan Hu, Brian L. Ellis, Ying Ying Yiu, +4

PLoS ONE

Inhibition of TYK2 and JAK1 Ameliorates Imiquimod-Induced Psoriasis-like Dermatitis by Inhibiting IL-22 and the IL-23/IL-17 Axis

Melissa Works, F Yin, Catherine Yin, +9

The Journal of Immunology

Sar-20347 DoseImmunologyImmune RegulationIl-23/il-17 AxisDermatology +15

A functional subset of CD8+ T cells during chronic exhaustion is defined by SIRPα expression

Lara Myers, Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, +17

Nature Communications

Bacillus thuringiensis-derived Cry5B Has Potent Anthelmintic Activity against Ascaris suum

Joseph F. Urban, Yan Hu, Melanie M. Miller, +3

PLoS neglected tropical diseases

BiologyParasitic DiseaseAscaris SuumAscaris LumbricoidesPathogenesis +9

Mechanistic and Single-Dose In Vivo Therapeutic Studies of Cry5B Anthelmintic Action against Hookworms

Yan Hu, Bin Zhan, Brian Keegan, +4

PLoS neglected tropical diseases

Upregulation of CD47 Is a Host Checkpoint Response to Pathogen Recognition

Michal Caspi Tal, Laughing Bear Torrez Dulgeroff, Lara Myers, +34

mBio

New Candidate Biomarkers in the Female Genital Tract to Evaluate Microbicide Toxicity

Scott A. Fields, Benben Song, Bareza A. Rasoul, +6

PLoS ONE

ImmunologyGynecologyPathologyFemale Reproductive SystemAntimicrobial Chemotherapy +24

Intramuscular SARS-CoV-2 vaccines elicit varying degrees of plasma and salivary antibody responses as compared to natural infection

George R. Nahass, Rachel E. Salomon-Shulman, Grace Blacker, +15

ImmunologySalivary Antibody ResponsesCovid-19Anti-rbd IggVaccine Target +14